In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus ... small segment of the market and “makes sweeping assertions about ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

Minnesota A.G. Keith Ellison says his office settled with Novo Nordisk to cap monthly out-of-pocket payments for insulin at ...

"I've always started with the ability to make decisions and make the right decisions," Rees said when he was asked what he looks for in a starting quarterback. "I want a decision-maker at the ...

In 2023, insulin manufacturer Eli Lilly voluntarily capped out-of-pocket costs for its insulin at $35 at participating pharmacies for people with commercial insurance. It also created a savings ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... which described it as "a tremendous step forward to make insulin accessible for all, regardless ...

It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...

One of the stars of “Emilia Pérez” has become the first openly transgender performer to be nominated for an Academy Award in an acting category. Karla Sofía Gascón was nominated for best ...